AKTX
AKARI THERP SP ADR (AKTX)
NASDAQ
$14.75+$0.11 (+0.79%)
Price as of Jun 03, 2026 7:56 PM EDT
  • $18.8M
    Market Cap
  • -72.71%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
9.3M
-3.97%
9.7M
-14.90%
11.4M
-16.05%
13.5M
+67.40%
Research and Development Expense
-2.8M
-59.69%
-7.0M
+28.13%
-5.5M
-43.00%
-9.6M
+4.68%
Depreciation and Amortization Expense
N/A
N/A
14,000
+250.00%
4,000
+7.87%
3,708
-10.13%
Total Operating Expenses
17.3M
-20.18%
21.6M
+90.59%
11.4M
-50.81%
23.1M
+34.12%
Operating Profit
-17.3M
-20.18%
-21.6M
+28.78%
-16.8M
-27.21%
-23.1M
+34.12%
Interest Income
1,000
-87.50%
8,000
-90.24%
82,000
+78.48%
45,944
+333.43%
Interest Expense
-100,000
0.00%
-100,000
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
-99,000
+7.61%
-92,000
-212.20%
82,000
+78.48%
45,944
+333.43%
Total Nonoperating Income and Expense
-1.0M
-155.40%
1.9M
+9,847.37%
-19,000
-100.36%
5.3M
+2,641.70%
Income before Taxes
-18.3M
-15.44%
-21.6M
+28.78%
-16.8M
-27.21%
-23.1M
+34.12%
Income Taxes
-1.0M
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
5.2M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-17.3M
-12.37%
-19.8M
+97.75%
-10.0M
-43.61%
-17.7M
+1.86%
Net Income from Continuing Operations Applicable to Common
-18.3M
-7.53%
-19.8M
+97.75%
-10.0M
-43.61%
-17.7M
+1.86%
Basic EPS and Net Income
0.00
N/A
0.00
N/A
0.00
N/A
0.00
N/A
Diluted EPS and Net Income
0.00
N/A
0.00
N/A
0.00
N/A
0.00
N/A
Basic Weighted Average Shares
67.3B
+181.85%
23.9B
+144.03%
9.8B
+56.79%
6.2B
+45.46%
Diluted Weighted Average Shares
67.3B
+181.85%
23.9B
+144.03%
9.8B
+56.79%
6.2B
+45.46%
Balance Sheet
Cash and Cash Equivalents
5.2M
+100.19%
2.6M
-32.41%
3.8M
-70.98%
13.2M
+41.54%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
5.2M
+100.19%
2.6M
-32.41%
3.8M
-70.98%
13.2M
+41.54%
Total Current Assets
5.5M
+85.03%
3.0M
-32.00%
4.3M
-68.58%
13.8M
+18.84%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
164,938
0.00%
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Total Assets
47.9M
-5.28%
50.6M
+1,061.01%
4.4M
-68.51%
13.8M
+18.75%
Income Taxes Payable
7.0M
-13.53%
8.0M
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
81,000
-75.08%
325,000
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
12.4M
-37.97%
19.9M
+21,080.85%
94,000
-0.13%
94,118
-98.11%
Total Long-Term Debt
673,000
-3.86%
700,000
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
31,000
-91.91%
383,000
N/A
N/A
N/A
3.7M
+15.44%
Total Liabilities
19.6M
-30.95%
28.3M
+518.08%
4.6M
-61.93%
12.0M
+97.60%
Retained Earnings
-264.6M
+7.00%
-247.3M
+8.70%
-227.5M
+4.60%
-217.5M
+8.89%
Total Stockholders Equity
N/A
N/A
22.2M
+9,806.99%
-229,000
-112.79%
1.8M
-67.76%
Total Shares Outstanding
90.5B
+70.22%
53.2B
+301.89%
13.2B
+77.76%
7.4B
+93.51%
Cash Flow
Cash from Operating Activities
-10.6M
-15.81%
-12.6M
-23.61%
-16.4M
-23.59%
-21.5M
+14.10%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
382,000
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
13.2M
+19.87%
11.0M
+56.52%
7.0M
-72.24%
25.3M
+76.93%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-35.23%
-51.12%
-72.08%
-34.51%
-110.06%
-21.00%
-139.31%
+4.95%
Return on Equity
N/A
N/A
-179.92%
-85.96%
-1,281.64%
+165.21%
-483.25%
+107.16%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.44
+198.18%
0.15
-99.68%
46.18
-68.54%
146.78
+6,179.67%
Cash Ratio
0.42
+222.84%
0.13
-99.68%
40.90
-70.94%
140.78
+7,379.15%
Debt-to-Equity Ratio
N/A
N/A
0.05
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
0.02
-22.66%
0.02
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow